Hironori Nakagami

This inventor holds 18 USPTO granted patents and 16 published patent applications, plus 4 CIPO patents and 9 EPO patents, primarily in Vaccine Development. Top assignees: Osaka University, Anges, Inc., Funpep Co., Ltd.. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hironori Nakagami. Retrieved from https://idiyas.com/inventor/hironori-nakagami

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 18 (Patent Applications = 16)

% Patents Active = 100.0

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 9 (Patent Applications = 20)

Average Co-Inventor Count = 4.2

ph-index = 3

Forward Citations = 30(Granted Patents)

Location History:

Ibaraki, JP (2010 - 2018)
Osaka, JP (2015 - 2023)
Suita, JP (2016 - 2024)

Company Filing History:

Ds Pharma Animal Health Co., Ltd.

Hosokawa Micron Corporation

where one patent can have more than one assignee

Years Active: 2010-2026

Loading Chart...

Areas of Expertise:

DNA Vaccine

Conjugate Vaccine

Immunogenic Composition

Peptide Therapy

Inflammatory Skin Disease

SARS-CoV-2

Therapeutic Method

Cytokine Secretion

Vascular Endothelial Growth

Disease-Causing Protein

Anti-Aging Peptide

VEGF-Specific Epitope

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12673097 - IMPROVED DNA VACCINE FOR SARS-COV-2 (2026-07-07),

2. 12070498 - Conjugate vaccine targeting a disease-causing biological protein (2024-08-27),

3. 11819537 - Preventive or therapeutic method for inflammatory skin disease (2023-11-21),

4. 11712466 - Vaccine composition (2023-08-01),

5. 11421025 - Treatment of IL-17A diseases (2022-08-23),

6. 11020464 - Immunogenic composition targeting S100A9 (2021-06-01),

7. 10980876 - Conjugate vaccine targeting a disease-causing biological protein (2021-04-20),

8. 10695420 - DNA-peptide combination vaccine (2020-06-30),

9. 10543261 - DNA vaccine containing VEGF-specific epitope and/or angiopoietin-2-specific epitope (2020-01-28),

10. 10517926 - Oligopeptide having proinflammatory cytokine secretion-inhibiting activity (2019-12-31),

11. 10463592 - Peptide with anti-aging effect and use thereof (2019-11-05),

12. 10233215 - Peptide and use thereof (2019-03-19),

13. 10112978 - Peptide and use thereof (2018-10-30),

14. 9913886 - DNA vaccine containing specific epitope of apolipoprotein (a) (2018-03-13),

15. 9872825 - Peptide with anti-aging effect and use thereof (2018-01-23),

Title: The Innovative Journey of Hironori Nakagami

Introduction: Hironori Nakagami, a pioneering inventor hailing from Suita, Japan, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Nakagami's recent patents include advancements in artificial intelligence algorithms for autonomous vehicles, wearable health monitoring devices, and sustainable energy solutions.

Career Highlights: With a career spanning over two decades, Nakagami has worked with leading tech companies in Japan, spearheading research and development projects that have led to numerous successful patent applications.

Collaborations: Throughout his career, Nakagami has collaborated with top researchers and engineers in the field, fostering a culture of innovation and excellence in all his projects.

Conclusion: Hironori Nakagami's relentless pursuit of innovation and his passion for creating technology that improves lives have solidified his position as a respected inventor in the global tech community.

Profile summary based on public USPTO records.